An interventional study of Whey protein and Dietary Supplement: Whey Protein With Adaptogenic Blend in Sports Nutritional Sciences, Sports Nutrition and Recovery, sponsored by Sports Performance and Applied Research in Trials and Analysis. Recruiting at 1 site in United Kingdom. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by Sports Performance and Applied Research in Trials and Analysis · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 390 studies in Motor Activity with a site in United Kingdom — 65 open to participants now, 79 under way, none of them phase 3. Motor Activity · United Kingdom.
Among the 390 studies in Motor Activity with a site in United Kingdom, this one is the 104th largest by planned enrollment of the 318 interventional ones that give a count, is one of 17 that started in 2026, is one of 292 with no phase, reaches primary completion later than 48 of the 78 other live ones, and was the 386th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →65 of the 390 studies in Motor Activity with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Surrey · Sites in United Kingdom
Ages 18+
Glasgow Caledonian University · Sites in United Kingdom
Ages 18+
Dr. Chris Gaffney · Sites in United Kingdom
Ages 60–85
University of Surrey · Sites in United Kingdom
Ages 18+
Sports Performance and Applied Research in Trials and Analysis · Sites in United Kingdom
Ages 18–45 · Women only · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 18 Years to 45 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
390 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 9 · Phase 2 13 · Phase 3 6 · Phase 4 2
First in 2002; this study’s year is marked. 17 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is close to the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 42 across the 318 interventional studies, 60 across the 72 observational. Of the 248 that completed or were terminated, 21 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 390 have an industry lead sponsor. The 10 most frequent:
Sports Performance and Applied Research in Trials and Analysis is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Sports Performance and Applied Research in Trials and Analysis has 2 studies filed under Motor Activity — fewer than ten, so there is no comparison to draw.
19 of the studies in Motor Activity with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06017934University of SouthamptonPromoting Increased Physical Activity in Hospitalised Older Adults | 2026-11 |
| NCT05889598Loughborough UniversityResistance Exercise Training to Improve Bone and Articular Cartilage Health in Women | 2026-12-31 |
| NCT07554677Queen's University, BelfastUnderstanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study | 2027-01-14 |
| NCT07135232Leeds Beckett UniversityThe Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. | 2027-03-01 |
| NCT07500948University of LeicesterEffectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation | 2027-03-31 |
Add all 19 to your calendar (.ics) → With an account.
Among the 390 studies in Motor Activity with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn whether whey protein, with or without an adaptogenic herb blend, can improve strength, recovery, stress, and wellbeing in active males. The adaptogenic blend contains 600mg ashwagandha root extract.The main questions the study aims to answer are:
Does whey protein improve muscle strength and recovery in physically active males? Does adding ashwagandha to whey protein further improve stress, recovery, sleep, and wellbeing compared with protein alone? Are there differences between whey protein when combined with the adaptogenic blend?
Researchers will compare two supplement groups:
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will consume a whey protein supplement daily for 6 weeks. Assessments of muscle strength, recovery, stress, wellbeing, dietary intake, and salivary biomarkers will be conducted at baseline and post-intervention.
Dietary Supplement: Whey protein
Participants will consume a whey protein supplement containing ashwagandha KSM-66® (600 mg) for 6 weeks. Assessments will be conducted at baseline and post-intervention.
Dietary Supplement: Dietary Supplement: Whey Protein With Adaptogenic Blend
Participants will consume a whey protein supplement for 6 weeks. The supplement will be provided in identical blank tubs. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.
Also known as: Grass-Fed Whey Protein, Whey Protein Powder
Participants will consume a whey protein supplement containing ashwagandha KSM-66® root extract (600 mg) for 6 weeks. Supplements will be provided in identical blank tubs. Participants will maintain usual diet and training habits during the study.
Also known as: Whey Protein Plus Adaptogens, Ashwagandha Whey Protein
Salivary Cortisol Concentration
Change in salivary cortisol concentration from baseline to post-intervention following 6 weeks of whey protein supplementation with or without an adaptogenic herb blend containing ashwagandha KSM-66®. Results will be reported in ng/mL.
Time frame: Time Frame: Baseline and Week 6
Handgrip Strength
Change in maximal handgrip strength measured using a CAMRY dynamometer from baseline to post-intervention.
Time frame: Time Frame: Baseline and Week 6
Upper Body Muscular Endurance
Change in upper body muscular endurance assessed using the 90-degree push-up test protocol from baseline to post-intervention.
Time frame: Time Frame: Baseline and Week 6
Perceived Recovery and Wellbeing
Participants will complete the Hooper Index Questionnaire, which assesses four domains: sleep quality, fatigue, stress, and muscle soreness. Each domain is rated on a 10-point Likert scale ranging from 1 to 10, with total scores ranging from 4 to 40. Higher scores indicate poorer wellbeing and recovery status, whereas lower scores indicate better perceived wellbeing and recovery.
Time frame: Time Frame: Baseline and Week 6
Salivary DHEA-S Concentration
Salivary DHEA-S concentration will be measured from saliva samples using enzyme-linked immunosorbent assay (ELISA) techniques. Results will be reported in ng/mL.
Time frame: Time Frame: Baseline and Week 6
Dietary Intake
Dietary intake assessed using a 24-hour dietary recall to evaluate habitual nutritional intake during the study period.
Time frame: Time Frame: Baseline and Week 6
Salivary Testosterone Concentration
Salivary testosterone concentration will be measured from saliva samples using ELISA. Results will be reported in pg/mL.
Time frame: Time Frame: Baseline and Week 6
Salivary Secretory Immunoglobulin A (sIgA) Concentration
Salivary secretory immunoglobulin A (sIgA) concentration will be measured from saliva samples using ELISA. Results will be reported in µg/mL.
Time frame: Time Frame: Baseline and Week 6
Salivary C-reactive Protein Concentration
Salivary C-reactive protein will be measured from saliva samples using ELISA. Results will be reported in pg/mL.
Time frame: Time Frame: Baseline to Week 6
Plan to share: No — Individual participant data (IPD) will not be shared with other researchers. Data collected in this study will be anonymised and retained only for the duration of analysis before permanent deletion, in accordance with the study protocol, participant consent, and UK GDPR requirements.
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for Nov 2026, 4 months after the start.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 4 months is below that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: primary completion Sep 2026 → Nov 2026 and completion Oct 2026 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sports Performance and Applied Research in Trials and Analysis